CompoSecure is revising its full year Net Sales guidance to $418-$424 million (previously $418-$428 million) and its Adjusted EBITDA guidance to $148-$151 million (previously $150-157 million) to ...

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO) today announced it ...

Samsung Biologics said on Friday that it was granted three certifications from the International Organization for ...